{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:58:20Z","timestamp":1792486700008,"version":"4.5.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jtauto.2025.100332","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T05:58:11Z","timestamp":1763272691000},"page":"100332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Rheumatoid factor and anti-citrullinated protein IgA antibodies in the diagnosis, prognosis and monitoring of patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"11","author":[{"given":"Ulrike","family":"Steffen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Sieghart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5089-7405","authenticated-orcid":false,"given":"G\u00fcnter","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2025.100332_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jtauto.2025.100332_bib2","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2025.100332_bib3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jtauto.2025.100332_bib4","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/rheumatology\/keae701","article-title":"Poor prognostic factors and unmet needs in rheumatoid arthritis","volume":"64","author":"Smolen","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100332_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","article-title":"Autoantibodies in rheumatoid arthritis: historical background and novel findings","volume":"63","author":"Sokolova","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"van Delft","year":"2020","journal-title":"J. Autoimmunity"},{"key":"10.1016\/j.jtauto.2025.100332_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/BOR.0000000000001006","article-title":"Autoantibodies in rheumatoid arthritis - rheumatoid factor, anticitrullinated protein antibodies and beyond","volume":"36","author":"Steiner","year":"2024","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.685312","article-title":"Autoantibodies in rheumatoid arthritis - Laboratory and clinical perspectives","volume":"12","author":"Ronnelid","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2025.100291","article-title":"Autoantibodies as prognostic markers in rheumatoid arthritis","volume":"10","author":"Turesson","year":"2025","journal-title":"Journal of translational autoimmunity"},{"key":"10.1016\/j.jtauto.2025.100332_bib10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/annrheumdis-2019-216822","article-title":"Erik Waaler (1903-1997): one of the founders of rheumatological immunology who discovered rheumatoid factor","volume":"79","author":"Jonsson","year":"2020","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.20160792","article-title":"Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor","volume":"213","author":"Tan","year":"2016","journal-title":"The Journal of experimental medicine"},{"key":"10.1016\/j.jtauto.2025.100332_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41584-019-0244-4","article-title":"The structure, specificity and function of anti-citrullinated protein antibodies","volume":"15","author":"Ge","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/ard-2023-224103","article-title":"Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?","volume":"83","author":"van der Woude","year":"2024","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib14","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.40562","article-title":"Triple positivity for anti-citrullinated protein autoantibodies, rheumatoid factor, and anti-carbamylated protein antibodies conferring high specificity for rheumatoid arthritis: implications for very early identification of At-Risk individuals","volume":"70","author":"Verheul","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003851","article-title":"Classification of rheumatoid arthritis: is it time to revise the criteria?","volume":"10","author":"Steiner","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.jtauto.2025.100332_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13075-015-0736-9","article-title":"Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials","volume":"17","author":"Aletaha","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100332_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/ard-2023-224728","article-title":"In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation","volume":"83","author":"Pertsinidou","year":"2024","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib18","article-title":"Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?","volume":"64S","author":"Holers","year":"2024","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2025.100332_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.21691","article-title":"Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis","volume":"55","author":"Caspi","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2025.100332_bib20","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/rheumatology\/keaf032","article-title":"Circulating secretory component-containing anti-citrullinated protein antibodies prior to symptom onset in rheumatoid arthritis","volume":"64","author":"Martinsson","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100332_bib21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s12026-024-09500-w","article-title":"The prognostic value of IgA anti-citrullinated protein antibodies and rheumatoid factor in an early arthritis population with a treat-to-target approach","volume":"72","author":"Heutz","year":"2024","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jtauto.2025.100332_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002817","article-title":"Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysis","volume":"9","author":"Motta","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.jtauto.2025.100332_bib23","article-title":"The diagnostic and prognostic value of IgG and IgA anti-citrullinated protein antibodies in patients with early rheumatoid arthritis","volume":"13","author":"Sieghart","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3389\/fimmu.2018.00876","article-title":"Determination of autoantibody isotypes increases the sensitivity of serodiagnostics in rheumatoid arthritis","volume":"9","author":"Sieghart","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002705","article-title":"Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk","volume":"9","author":"Sokolova","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.jtauto.2025.100332_bib26","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/ar2449","article-title":"Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project","volume":"10","author":"Svard","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100332_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/antib8040057","article-title":"IgA: structure, function, and developability","volume":"8","author":"de Sousa-Pereira","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.jtauto.2025.100332_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1146\/annurev-micro-032521-041803","article-title":"License to clump: secretory IgA structure-function relationships across scales","volume":"77","author":"Hockenberry","year":"2023","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.jtauto.2025.100332_bib29","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1126\/science.aaz5807","article-title":"Structure of the secretory immunoglobulin A core","volume":"367","author":"Kumar","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jtauto.2025.100332_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-019-13992-8","article-title":"IgA subclasses have different effector functions associated with distinct glycosylation profiles","volume":"11","author":"Steffen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2025.100332_bib31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/mi.2011.39","article-title":"Structure and function relationships in IgA","volume":"4","author":"Woof","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1074\/mcp.R112.026005","article-title":"Glycoproteomic analysis of antibodies","volume":"12","author":"Zauner","year":"2013","journal-title":"Mol. Cell. Proteomics : MCP"},{"key":"10.1016\/j.jtauto.2025.100332_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1116435","article-title":"IgA2 immune complexes selectively promote inflammation by human CD103(+) dendritic cells","volume":"14","author":"Mes","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0090-1229(86)90073-5","article-title":"The human IgA system: a reassessment","volume":"40","author":"Mestecky","year":"1986","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jtauto.2025.100332_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-101320-123742","article-title":"Molecular mechanisms of multimeric assembly of IgM and IgA","volume":"40","author":"Matsumoto","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22058","article-title":"High-avidity IgA protects the intestine by enchaining growing bacteria","volume":"544","author":"Moor","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2025.100332_bib37","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1038\/s41467-023-42469-y","article-title":"SIgA structures bound to Streptococcus pyogenes M4 and human CD89 provide insights into host-pathogen interactions","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2025.100332_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.immunol.21.120601.141011","article-title":"IgA Fc receptors","volume":"21","author":"Monteiro","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4049\/jimmunol.166.1.346","article-title":"A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes","volume":"166","author":"Geissmann","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib40","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI116754","article-title":"Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals","volume":"92","author":"Monteiro","year":"1993","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.jtauto.2025.100332_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.171.3.597","article-title":"Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans","volume":"171","author":"Monteiro","year":"1990","journal-title":"The Journal of experimental medicine"},{"key":"10.1016\/j.jtauto.2025.100332_bib42","doi-asserted-by":"crossref","first-page":"29781","DOI":"10.1074\/jbc.270.50.29781","article-title":"Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89\/FcR gamma chain association","volume":"270","author":"Morton","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jtauto.2025.100332_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/imcb.12306","article-title":"Serum IgA Fc effector functions in infectious disease and cancer","volume":"98","author":"Davis","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jtauto.2025.100332_bib44","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.autrev.2012.10.011","article-title":"Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives","volume":"12","author":"Ben Mkaddem","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100332_bib45","first-page":"335","article-title":"ELISA determined IgM, IgG and IgA rheumatoid factors in rheumatoid arthritis and in other connective tissue diseases","volume":"5","author":"Procaccia","year":"1987","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002960050069","article-title":"Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis","volume":"18","author":"Jonsson","year":"1998","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jtauto.2025.100332_bib47","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1515\/cclm-2022-0244","article-title":"IgA rheumatoid factor in rheumatoid arthritis","volume":"60","author":"Van Hoovels","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jtauto.2025.100332_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627986","article-title":"A comprehensive evaluation of the relationship between different IgG and IgA anti-modified protein autoantibodies in rheumatoid arthritis","volume":"12","author":"Gronwall","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib49","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chest.2019.12.005","article-title":"IgA antibodies directed against citrullinated protein antigens are elevated in patients with idiopathic pulmonary fibrosis","volume":"157","author":"Solomon","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jtauto.2025.100332_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17218054","article-title":"Levels of anti-citrullinated protein antibodies and rheumatoid factor, including IgA isotypes, and articular manifestations in ulcerative colitis and Crohn's Disease","volume":"17","author":"Janssen","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.jtauto.2025.100332_bib51","first-page":"237","article-title":"Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests, Clinica chimica acta","volume":"436","author":"Infantino","year":"2014","journal-title":"international journal of clinical chemistry"},{"key":"10.1016\/j.jtauto.2025.100332_bib52","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/ar4148","article-title":"Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study","volume":"15","author":"Bizzaro","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100332_bib53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/ard.43.5.673","article-title":"Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor","volume":"43","author":"Teitsson","year":"1984","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/ard.43.5.679","article-title":"Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity","volume":"43","author":"Withrington","year":"1984","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.46.5.380","article-title":"Relation between bone erosions and rheumatoid factor isotypes","volume":"46","author":"Arnason","year":"1987","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib56","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/03009749509095183","article-title":"Raised IgA rheumatoid factor (RF) but not IgM RF or IgG RF is associated with extra-articular manifestations in rheumatoid arthritis","volume":"24","author":"Jonsson","year":"1995","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib57","first-page":"2119","article-title":"Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis","volume":"24","author":"Houssien","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib58","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/030097498442352","article-title":"Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis","volume":"27","author":"Pai","year":"1998","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","article-title":"Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset","volume":"65","author":"Berglin","year":"2006","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib60","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2025.100332_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13075-016-0940-2","article-title":"Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis","volume":"18","author":"Brink","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100332_bib62","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/03009742.2022.2127245","article-title":"Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study","volume":"52","author":"Rasmussen","year":"2023","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib63","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.2009.116384","article-title":"The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib64","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar3237","article-title":"Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis","volume":"13","author":"Kokkonen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100332_bib65","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10067-006-0343-x","article-title":"Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study","volume":"26","author":"Ates","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001278","article-title":"Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis","volume":"6","author":"Joshua","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.jtauto.2025.100332_bib67","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12891-021-04985-0","article-title":"Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis","volume":"23","author":"Oka","year":"2022","journal-title":"BMC Muscoskelet. Disord."},{"key":"10.1016\/j.jtauto.2025.100332_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152004","article-title":"Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: clinical features, biomarkers, and treatment options","volume":"55","author":"Chen","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2025.100332_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.62.5.407","article-title":"Diagnostic strategy for the assessment of rheumatoid vasculitis","volume":"62","author":"Voskuyl","year":"2003","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib70","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.41381","article-title":"Anti-Citrullinated protein antibody specificities, rheumatoid factor isotypes, and incident cardiovascular events in patients with rheumatoid arthritis","volume":"72","author":"Westerlind","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib71","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2006.060608","article-title":"High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis","volume":"66","author":"Bobbio-Pallavicini","year":"2007","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib72","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00296-012-2560-8","article-title":"Immunoglobulin subtypes predict therapy response to the biologics in patients with rheumatoid arthritis","volume":"33","author":"Can","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jtauto.2025.100332_bib73","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1756-185X.12443","article-title":"IgA rheumatoid factor as a serological predictor of poor response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis","volume":"17","author":"Sakthiswary","year":"2014","journal-title":"International journal of rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib74","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.rdc.2009.10.006","article-title":"The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical care","volume":"35","author":"Aletaha","year":"2009","journal-title":"Rheumatic diseases clinics of North America"},{"key":"10.1016\/j.jtauto.2025.100332_bib75","doi-asserted-by":"crossref","first-page":"ii15","DOI":"10.1093\/rheumatology\/keaf035","article-title":"Rheumatoid factors revisited in the age of biologic therapy","volume":"64","author":"Avci","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100332_bib76","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/ard.2010.148759","article-title":"Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries","volume":"70","author":"Chatzidionysiou","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib77","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/annrheumdis-2011-201109","article-title":"Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry","volume":"71","author":"Gottenberg","year":"2012","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib78","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cei.13206","article-title":"Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis","volume":"194","author":"Kastbom","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib79","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3390\/jcm14051529","article-title":"Rheumatoid factor: diagnostic and prognostic performance and therapeutic implications in rheumatoid arthritis","volume":"14","author":"Togashi","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jtauto.2025.100332_bib80","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/annrheumdis-2021-221849","article-title":"Standardisation of ACPA tests: evaluation of a new candidate reference preparation","volume":"81","author":"Van Hoovels","year":"2022","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib81","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/cei.13381","article-title":"Secretory antibodies to citrullinated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first-degree relatives","volume":"199","author":"Svard","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2025.100332_bib83","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard-2022-223134","article-title":"Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking","volume":"82","author":"Tang","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2025.100332_bib84","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/ard.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","volume":"67","author":"Makrygiannakis","year":"2008","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-015-0520-x","article-title":"Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis","volume":"17","author":"Lugli","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100332_bib86","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jbspin.2020.04.024","article-title":"Rheumatoid arthritis risk in periodontitis patients: a systematic review and meta-analysis","volume":"87","author":"Qiao","year":"2020","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.jtauto.2025.100332_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/annrheumdis-2012-202726","article-title":"Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis","volume":"73","author":"Quirke","year":"2014","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib88","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0022034519898144","article-title":"The P. gingivalis autocitrullinome is not a target for ACPA in early rheumatoid Arthritis","volume":"99","author":"Munoz-Atienza","year":"2020","journal-title":"Journal of dental research"},{"key":"10.1016\/j.jtauto.2025.100332_bib89","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/rheumatology\/keaa792","article-title":"Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis","volume":"60","author":"Rooney","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100332_bib90","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","article-title":"Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis","volume":"11","author":"Tajik","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2025.100332_bib91","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/rheumatology\/keac237","article-title":"In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis","volume":"62","author":"Derksen","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100332_bib92","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/rheumatology\/39.11.1202","article-title":"Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis","volume":"39","author":"Masdottir","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100332_bib93","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3899\/jrheum.101086","article-title":"A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis","volume":"38","author":"Svard","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib94","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13075-025-03543-6","article-title":"Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies - comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis","volume":"27","author":"van Wesemael","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100332_bib95","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/art.1780291003","article-title":"Molecular forms of IgA rheumatoid factor in serum and synovial fluid of patients with rheumatoid arthritis","volume":"29","author":"Schrohenloher","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2025.100332_bib96","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.40066","article-title":"Anti-Citrullinated protein antibodies are associated with neutrophil extracellular traps in the sputum in relatives of rheumatoid arthritis patients","volume":"69","author":"Demoruelle","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib97","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/rheumatology\/kez377","article-title":"Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis","volume":"59","author":"Roos Ljungberg","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100332_bib98","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.imbio.2012.04.011","article-title":"Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis","volume":"218","author":"Svard","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.jtauto.2025.100332_bib99","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/art.43036","article-title":"Evidence of site-specific mucosal autoantibody secretion in rheumatoid arthritis","volume":"77","author":"Derksen","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib100","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/rheumatology\/keab585","article-title":"IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritis","volume":"61","author":"Sokolova","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100332_bib101","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jcpe.13277","article-title":"Increased IgA anti-citrullinated protein antibodies in the periodontal inflammatory exudate of healthy individuals compared to rheumatoid arthritis patients","volume":"47","author":"Rahajoe","year":"2020","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.jtauto.2025.100332_bib102","first-page":"699","article-title":"Antibodies to citrullinated peptides in serum and saliva in patients with rheumatoid arthritis and their association to periodontitis","volume":"38","author":"Svard","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib103","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/art.39771","article-title":"Elevated IgA plasmablast levels in subjects at risk of developing rheumatoid arthritis","volume":"68","author":"Kinslow","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib104","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.1300261","article-title":"IgA enhances NETosis and release of neutrophil extracellular traps by polymorphonuclear cells via Fcalpha receptor I","volume":"192","author":"Aleyd","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V97.1.205","article-title":"Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor gamma-chain signaling","volume":"97","author":"Shen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtauto.2025.100332_bib106","article-title":"IgA complexes induce neutrophil extracellular trap Formation more potently than IgG complexes","volume":"12","author":"Gimpel","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib107","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.4049\/jimmunol.174.9.5472","article-title":"Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors","volume":"174","author":"Otten","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.649693","article-title":"Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: same foe different M.O","volume":"12","author":"Fresneda Alarcon","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib109","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis, Science Transl","volume":"5","author":"Khandpur","year":"2013","journal-title":"Med."},{"key":"10.1016\/j.jtauto.2025.100332_bib110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/art.41062","article-title":"A neutrophil activation biomarker Panel in prognosis and monitoring of patients with rheumatoid arthritis","volume":"72","author":"Bach","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib111","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2017.04.007","article-title":"Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients","volume":"82","author":"Perez-Sanchez","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2025.100332_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106420","article-title":"Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease","volume":"182","author":"Saku","year":"2021","journal-title":"Respir. Med."},{"key":"10.1016\/j.jtauto.2025.100332_bib113","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/rheumatology\/kead641","article-title":"Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis","volume":"64","author":"Sejersen","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2025.100332_bib114","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/1756-185X.13226","article-title":"Increased levels of neutrophil extracellular trap remnants in the serum of patients with rheumatoid arthritis","volume":"21","author":"Wang","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2025.100332_bib115","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.4049\/jimmunol.1502353","article-title":"IgA complexes in plasma and synovial fluid of patients with rheumatoid arthritis induce neutrophil extracellular traps via FcalphaRI","volume":"197","author":"Aleyd","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib116","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.41948","article-title":"Association of Sputum Neutrophil extracellular trap subsets with IgA anti-citrullinated protein antibodies in subjects at risk for rheumatoid arthritis","volume":"74","author":"Okamoto","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib117","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1053\/j.gastro.2009.06.047","article-title":"Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4","volume":"137","author":"van der Steen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2025.100332_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451586","article-title":"IgA2 ACPA drives a hyper-inflammatory phenotype in macrophages via ATP synthase and COX2","volume":"55","author":"Almeida","year":"2025","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib119","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.4049\/jimmunol.1700883","article-title":"Serum IgA immune complexes promote proinflammatory cytokine production by human macrophages, monocytes, and kupffer cells through FcalphaRI-TLR cross-talk","volume":"199","author":"Hansen","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib120","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.4049\/jimmunol.1402334","article-title":"IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies","volume":"194","author":"Anquetil","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.651049","article-title":"IgA immune complexes induce osteoclast-mediated bone resorption","volume":"12","author":"Breedveld","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100332_bib122","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/03009742.2017.1416668","article-title":"Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy","volume":"47","author":"Fedele","year":"2018","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib123","first-page":"301","article-title":"IgA isotype rheumatoid factor in rheumatoid arthritis: clinical implications","volume":"14","author":"Jorgensen","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib124","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/ard-2023-224211","article-title":"Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease","volume":"84","author":"Deane","year":"2025","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.jtauto.2025.100332_bib125","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41584-023-01035-y","article-title":"Rheumatoid arthritis prevention in arthralgia: fantasy or reality?","volume":"19","author":"van Steenbergen","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100332_bib126","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ard.2025.01.021","article-title":"EULAR\/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia","author":"van Steenbergen","year":"2025","journal-title":"Annals of the rheumatic diseases 84"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902500067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902500067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:19:15Z","timestamp":1765358355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258990902500067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":126,"alternative-id":["S258990902500067X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100332","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid factor and anti-citrullinated protein IgA antibodies in the diagnosis, prognosis and monitoring of patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100332"}}